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Abstract
AIM: To compare the results of high-resolution ultra-
sound (HR-US) and magnetic resonance enterography 
(MRE) examinations in patients with inflammatory bowel 
disease (IBD).
METHODS: The reports of 250 consecutive cases with 
known IBD, who had an MRE and HR-US examination, 
were retrospectively analyzed. Using a patient-based 
approach we evaluated morphological disease features 
such as affected bowel wall, stenosis, abscess and fis-
tula. The comparison between the two modalities was 
based on the hypothesis, that any pathological change 
described in any imaging modality was a true finding, as 
no further standard of reference was available for com-
plete assessment.
RESULTS: Two hundred and fifty examinations rep-
resenting 207 different patients were evaluated. Both 
modalities assessed similar bowel wall changes in 65% 
of the examinations, with more US findings in 11% and 
more MRE findings in 15%. When the reports were 
analyzed with regard to “bowel wall inflammation”, 
US reported more findings in 2%, while MRE reported 
more findings in 53%. Stenoses were assessed to be 
identical in 8%, while US found more in 3% and MRE 
in 29% (P  < 0.01). For abscess detection, US showed 
more findings in 2% (n = 4) while MRE detected more 
in 6% (n  = 16). US detected more fistulas in 1% (n = 2), 
while MRE detected more in 13% (n = 32) (P  < 0.001). 
The most common reason for no detected pathology by 
US was a difficult to assess anatomical region (lesser 
pelvis, n  = 72).
CONCLUSION: US can miss clinically relevant patho-
logical changes in patients with IBD mostly due to dif-
ficulty in assessing certain anatomical regions.
© 2011 Baishideng. All rights reserved.
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INTRODUCTION
Patients suffering from inflammatory bowel disease (IBD) 
need a complete bowel assessment for their primary diag-
nosis. In addition, follow-up examinations are necessary 
during deterioration of  clinical symptoms or for therapy 
monitoring.
According to most recent national or international guide-
lines, high-resolution ultrasound (HR-US) should be the 
first-line diagnostic modality for disease assessment or 
follow up examinations[1,2]. If  an IBD is assumed, several 
guidelines recommend a complete sectional imaging of  
the small bowel. Because of  the lack of  any ionizing radia-
tion, a dedicated magnetic resonance imaging (MRI) ex-
amination of  the small bowel is therefore recommended. 
Currently magnetic resonance (MR) enteroclysis with 
contrast application via a naso-jejunal tube as well as MR 
enterography (MRE), where the contrast is applied orally, 
are the methods of  choice. Because of  the expensive 
radiological equipment and the need for intravenously ap-
plied contrast media, MRE is an examination which is less 
available and more cost intensive compared to HR-US. 
On the other hand, US is more subjective and highly de-
pendent on the experience of  the examiner, but requires 
less expensive equipment.
The current literature shows excellent sensitivity of  
between 78% and 96% with specificity between 67% 
and 100% for HR-US in IBD[3]. On the other hand, 
MRE shows sensitivity of  between 82% and 100% with 
specificity between 71% and 100%. Most studies were 
performed in an academic environment by specialists 
in their field. In our experience a total small bowel as-
sessment by HR-US during daily routine is difficult to 
perform. Several segments of  the bowel cannot be visu-
alized by US because of  residual air in the bowel, ana-
tomical obstacles in the pelvic region or superposition of  
other bowel loops.
To assess the diagnostic and therapeutic impact of  
HR-US and MRE in patients with IBD in a day-to-day 
clinical setting, we decided to perform a retrospective 
study. By analyzing and comparing the written reports 
retrospectively, we intended to avoid the study bias some-
times caused by extremely motivated study examiners, and 
depict the report quality for both modalities under every-
day circumstances.
In this study we compared and evaluated the results 
of  HR-US and MRE examinations in patients suffer-
ing from IBD, with regard to clinically relevant disease 
features such as bowel wall affection, stenosis, fistula, 
abscess and indirect inflammation indicators such as local 
lymphadenopathy, mesenteric fat injection or enlarged lo-
cal vessels.
MATERIALS AND METHODS
Patient selection
Using our radiological information system, we retrospec-
tively searched for patients who underwent an MRE ex-
amination between October 1999 and January 2007 in our 
tertiary care medical center. After identifying 1582 MRE 
examinations during this period, we selected all patients in 
this group with histologically and clinically proven IBD, 
resulting in 801 MRE examinations. Based on these 801 
cases we evaluated all patients who had a HR-US exami-
nation within a 14-d period before or after MRE. Based 
on this selection we chose 250 consecutive cases for fur-
ther analysis.
MRE examination
MRE was performed using a 1.5-Tesla MRI unit (Mag-
netom Symphony and Magnetom Sonata, Siemens 
Healthcare, Erlangen, Germany) using a circular polar-
ized 6-channel phased array body coil supplemented with 
a spine array coil. The dark lumen technique with an oral 
contrast of  1.5-2 L of  water mixed with methylcellulose 
was applied. A coronal True-fast imaging with steady state 
precession sequence and an axial T2-weighted half-Fourier 
acquired single-shot turbo spin echo sequence were ac-
quired. Subsequently, 0.1 mmol/kg body weight of  Gd-
DTPA (different vendors during the examination period) 
was injected intravenously. A fat-suppressed 3D gradient 
echo sequence and a fat-suppressed T1-weighted 2D gradi-
ent echo sequence with axial and coronal orientation were 
acquired with a delay of  70 s after the start of  the contrast 
injection.
If  the clinical examination or anamnesis suggested 
fistulas, additional sequences with 4 mm slice thickness 
(axial and coronal T2 short tau inversion recovery and T1-
weighted sequences before and after Gd-DTPA iv) were 
acquired. The MRE examinations were evaluated by a 
board certified radiologist and an experienced resident, re-
sulting in a written and electronically documented report 
based on a consensus decision.
HR-US
HR-US of  the bowel was performed in our interdisci-
plinary ultrasound department by a resident in internal 
medicine, surgery or radiology or by a consultant in inter-
nal medicine. To evaluate the influence of  the individual 
experience of  the examiner on the examination results in 
ultrasound, we subdivided the examiners into groups with 
moderate and high experience. Examiners with high ex-
perience were board certified with more than 2000 docu-
mented ultrasound examinations per year.
For a clinical routine ultrasound examination of  the 
bowel, a 3.5 MHz convex transducer was applied first. A 
high-resolution 5 to 10 MHz transducer was then used 
for bowel imaging. During the evaluation period we used 
several ultrasound devices: SonolineElegra (Siemens, Er-
langen, Germany), Logiq 9 (General Electric, Solingen, 
Germany) or EUB-8500 (Hitachi, Tokyo, Japan). Ultra-
sound images were documented in soft prints as part of  
the patient record. An electronically documented report 
of  the examination was available for all patients.
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Data analysis
We retrospectively evaluated the electronically documented 
reports of  MRE and US examinations without reviewing 
the original imaging data. The 250 cases were evaluated 
in a patient-based analysis with regard to the following 
categories: affected bowel wall, bowel stenosis, abscess, 
fistula, local lymphadenopathy and local fat injection or 
comb sign. The evaluation of  these categories was based 
on the written report of  each modality.
For MRE, the bowel wall was deemed affected when 
having a diameter of  at least 3 mm and/or showing in-
creased contrast uptake. For ultrasound examinations a 
bowel wall diameter larger than 3 mm was also considered 
as “thickened bowel”. A thickened bowel wall larger than 
3 mm without any data on contrast enhancement of  vas-
cularization is a very unspecific finding. For routine HR-
US examinations of  the bowel, an intravenous contrast 
application is currently not an established standard. Vas-
cularization information based on Power Doppler imaging 
was integrated into the ultrasound findings. The mention 
of  an “accentuated” or “slightly thickened” bowel wall in 
a written ultrasound report is not very specific. For our 
comparison we separately evaluated the assessment of  the 
bowel wall of  each modality regarding the terms “affected” 
or “inflamed”, which represents a clear clinical statement, 
and “accentuated” and “slightly thickened”, which is an 
unspecific statement without immediate clinical conse-
quences.
For bowel stenosis in MRE and US the term “steno-
sis” as well as “narrowed bowel lumen” was considered 
as a positive finding. For the diagnosis of  an abscess or a 
fistula the term had to be mentioned in the report. Local 
lymphadenopathy was not restricted to a certain size or 
amount of  lymph nodes. In this study, the descriptive term 
“lymphadenopathy” as well as “enlarged” or “multiple” 
lymph nodes represented the diagnosis of  local lymph-
adenopathy. The diagnosis of  a local fat injection was 
made when terms such as “injected mesenteric fat” were 
used. The comb sign as an indirect inflammation criterion 
caused by enlarged vasa recta surrounding the affected 
bowel was diagnosed with the mention of  “comb sign” or 
the finding of  enlarged or accentuated local vessels[4].
In the patient-based analysis we focused on all cases 
with identified pathological findings in only one modality, 
which were not noted in the other modality report. Pos-
sible reasons for discrepant findings were analyzed and 
noted.
Statistical significance was calculated using the Chi-test 
by McNemar. P-values ≤ 0.05 were considered statisti-
cally significant while P values ≤ 0.01 were considered 
highly significant. Descriptive statistics were calculated 
using Excel (Office: Mac 2008, Version 12.2.5; Microsoft, 
Redmond, WA, USA). Significance levels were calculated 
using SPSS for Windows 16 (SPSS, Chicago, IL, USA).
RESULTS
We evaluated a total of  250 consecutive cases of  patients 
with known IBD, where a MRE and a HR-US examina-
tion of  the bowel were performed within 14 d. The 250 
cases were based on 207 patients. The 207 patients had a 
mean age of  35.6 years (range 14-77 years; 55% female, 
45% male). The evaluated patients suffered from Crohn’s 
disease (CD; 84.5%, n = 175) or ulcerative colitis (UC; 
15.5 %, n = 32).
In 69% of  all evaluated cases ultrasound was per-
formed before MRE, in 16% MRE and ultrasound were 
performed on the same day, while in 15% MRE was per-
formed before ultrasound. On average, HR-US was per-
formed 1.9 d before MRE. In 90% of  all cases the time 
period between MRE and ultrasound was less than 7 d, in 
72% both examinations were performed within 3 d.
During the evaluation period we found a total of  100 
different examiners for high-resolution bowel ultrasound. 
Of  these examiners, 13 were considered highly experi-
enced (13%) while 87% had moderate experience in ultra-
sound. The highly experienced examiners performed 48% 
(n = 119) of  all bowel examinations.
Affected bowel wall
In the 250 cases evaluated both modalities described 
no bowel wall pathology in 21 cases. In the remain-
ing 229 cases, a total of  673 changes of  the bowel wall 
were described with 439 changes described by MRE and 
405 changes described by US. The described changes 
included subtle and unspecific findings such as “accentu-
ated bowel wall” without any specific diagnostic state-
ment. With regard to all bowel wall changes, there was no 
statistically significant difference between MRE and US 
(Table 1). MRE and ultrasound had similar results in 163 
cases, while MRE detected more lesions in 38 cases and 
US found more affected bowel wall segments in 28 cases. 
When analyzing the 28 cases with more lesions found on 
US, we had no explanation for the negative MRE findings 
in 10 of  the 28 cases. For 12 cases, possible explanations 
were subtle US findings describing a wall thickness of  
3 mm as an accentuated bowel wall. In 6 patients the 
MRE report stated inferior image quality due to breath-
ing and motion artifacts.
When analyzing the subgroup of  28 cases with more 
US findings with regard to the examiner’s experience, 43% 
(n = 12) of  the cases were examined by moderately expe-
rienced examiners (9 cases with possible explanations and 
3 cases with no explanation), while 57% (n = 16) where 
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Table 1  Contingency table of all evaluated 250 cases (patient 
based)  n  (%)
Any bowel wall changes (including unspecific 
changes such as “accentuated wall”, etc. )
Ultrasound
Negative Positive
Magnetic resonance enterography
   Negative 21 (8.4)   28 (11.2)
   Positive   38 (15.2) 163 (65.2)
Negative findings means no bowel wall change found in the modality 
(magnetic resonance enterography or ultrasound) report.
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examined by the highly experienced group (9 cases with 
possible explanations and 7 cases with no explanation). 
Based on these data, there was no relevant tendency or 
statistical relevance regarding the examiner’s experience 
(Table 2).
For the 38 cases with a superior MRE examination we 
had no explanation for the inferior US in 18 cases. For 
the remaining cases, restricted image quality was stated 
in 14 cases. Additionally, in 12 cases (in some cases more 
than one explanation for the same case was reported) the 
pathological changes were in anatomical areas with a dif-
ficult access by US (lesser pelvis, rectum). The 38 cases 
were performed by 13 highly experienced examiners and 
25 moderately experienced examiners.
Different results emerged when analyzing diagnostic 
statements such as “inflammation” and “affected bowel 
wall” only (Table 3). Restricted to these terms, which 
represent a definite diagnostic statement with therapeutic 
consequences, we found only 29 cases with similar results. 
There were six cases, where US detected more lesions 
than MRE and 132 cases (53%) where MRE described 
inflamed and affected bowel wall without US findings.
Stenosis
In 170 of  250 cases (68%) there was a consensus be-
tween US and MRE, while in 80 cases (32%) the findings 
regarding a stenosis were different (Table 4). In 72 cases 
(29%) the MRE examination described a stenosis, while 
the US was negative. For 18 of  72 cases there was no 
explanation for the negative ultrasound findings. In 54 
cases we found possible explanations. In 23 patients the 
stenosis was localized in an area which was difficult to 
assess by US. In 20 patients, the US image quality deterio-
rated due to residual bowel air. In 19 cases an explanation 
can be assumed because of  a subtle finding in the MRE. 
The MRE findings were just reported as a “narrowing of  
the lumen” without mentioning the word “stenosis” or 
describing indirect signs such as “pre-stenotic dilatation”.
The moderately experienced examiners performed 
44 of  the 72 cases with a superior MRE result, while the 
highly experienced examiners performed 28 of  these 
examinations (Table 2). In 8 cases (3%) a stenosis was 
described in the US report having a negative MRE. The 
8 cases with more US findings were examined only by 
highly experienced examiners.
Abscess
In the majority of  all cases (221 cases, 88%) we did not 
find any abscesses (Table 4). In 16 cases (6%) MRE de-
tected an abscess which was not described by US and in 
4 cases (2%) US described an abscess not mentioned in 
the MRE report. These 4 cases were assessed by 2 mod-
erately and 2 highly experienced examiners.
For the 16 cases with an abscess described by MRE 
and not by US there was no explanation in 1 case, where 
several abscesses with a diameter of  1 cm in the region of  
the cecum and terminal ileum were described in the MRE 
report. For 13 cases, a possible explanation was assumed 
to be difficult access mostly in the lesser pelvis, and for 
another 2 cases reduced image quality. Highly experienced 
examiners (n = 9) and moderately experienced examiners (n 
= 7) were equally distributed in these 16 cases.
Fistula
Two hundred and eleven of  250 cases (84%) showed no 
fistulas in either of  the modalities (Table 4). In 5 cases 
(2%) both modalities detected a fistula in the same pa-
tient while US identified 2 fistulas (1%), which were not 
described in the MRE report. We identified 32 cases (13%) 
where MRE identified fistulas not described by US. The 2 
cases with more US findings were performed by a highly 
experienced examiner. 
Thirty two cases of  fistula were detected by MRE which 
were not identified by US. In 24 cases a possible explana-
tion was difficult access for US, while in 9 cases reduced 
image quality was stated in the US report. Nineteen mod-
erately experienced and 13 highly experienced examiners 
performed these 32 examinations. There was no statistical 
significance in the examiners experience.
Local lymphadenopathy
Because the exact measured diameter was mentioned in 
just 4 cases for US and MRE we were unable to compare 
these data quantitatively. Based on both modalities, local 
lymphadenopathy was reported in 63 of  250 cases (25%). 
In 4 cases, MRE as well as US described enlarged or mul-
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Table 2  Influence of the experience of the ultrasound exam-
iner on diagnosis
Pathological changes Ultrasound examiner 
with moderate 
experience (%)
Ultrasound 
examiner with high 
experience (%)
MRI found more lesions 
than ultrasound
   Stenosis (n = 72) 62   38
   Abscess (n = 16) 46   46
   Fistula (n = 32) 59   41
Ultrasound found more 
lesions than MRI
   Stenosis (n = 8)   0 100
   Abscess (n = 4) 50   50
   Fistula (n = 2)   0 100
The percentage indicates the ratio of moderate or experienced ultrasound 
examiners in this scenario. MRI: Magnetic resonance imaging.
Table 3  Contingency table of all evaluated 250 cases (patient 
based)  n  (%)
Statement “inflammation” or “bowel 
wall affection” in the report 
Ultrasound
Negative Positive
Magnetic resonance enterography
   Negative   83 (33.2) 6 (2.4)
   Positive 132 (52.8) 29 (11.6)
Negative findings means no bowel wall affection or inflammation assessed 
based on the report (magnetic resonance enterography or ultrasound).
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tiple local lymph nodes, while lymphadenopathy was re-
ported in 15 cases solely by US (6%) and in 44 cases solely 
by MRE (18%).
Local fat injection and comb sign
A total of  68 cases (27%) with signs of  indirect inflam-
mation such as local fat injection or comb sign were de-
tected based on both modalities. In 4 cases, US and MRE 
identified these signs, while US described 4 additional 
cases (2%), which were not described by MRE. In the 
MRE reports, 60 cases (24%) with positive findings of  
indirect inflammatory signs were found, which were not 
described in the US report.
Reasons for discrepant findings
When analyzing all these results, when one modality de-
scribed a pathological finding, which was not described 
by the other modality, we detected several circumstances 
and possible reasons for this misdiagnosis (Table 5). In 
most cases (n = 72) a possible reason for misdiagnosis 
was the anatomical region, which was difficult to access 
by US such as the lesser pelvis and peri-rectal tissue. In 
particular, the localization of  fistulas in the pelvis is fre-
quently an obstacle for abdominal US diagnosis. Other 
reasons were reduced image quality on US due to obesity 
or residual bowel air in 25 patients and inadequate bowel 
distension or breathing artifacts in 7 patients on MRE 
examination.
In most evaluations, a higher ratio of  detected lesions 
by US was found for examiners with a higher level of  
experience, however, this influence was not demonstrated 
with any statistical significance (Table 2).
DISCUSSION
Our study retrospectively evaluated the results of  reports 
based on MRE and HR-US examinations in 250 consecu-
tive patients with known IBD.
By analyzing the bowel wall changes on a patient basis 
we obtained different results when evaluating different 
key words in the reports. When we evaluated all the terms 
regarding bowel wall changes including unspecific terms 
such as “accentuated bowel wall” or “wall thickening” 
we did not show statistically relevant differences between 
HR-US and MRE. In this scenario, the HR-US misses 
totaled 38 cases (15%) and the MRE misses totaled 28 
cases (11%), which were described in the opposite mo-
dality, respectively. Assuming that MRE depicts the whole 
abdomen including the bowel wall quite objectively, one 
of  the main reasons for these differences could be, that 
HR-US sometimes subjectively overestimates bowel wall 
thickening without giving exact measurements. In this 
study, we found this in at least 12 of  the 28 cases, when 
US described a thickening without a correlation in MRE. 
A possible reason for this was a very subtle finding men-
tioning a wall thickness between 2 mm and 3 mm. In the 
MRE findings, there were no signs of  inflammation such 
as increased contrast uptake or indirect inflammation fea-
tures. Therefore, HR-US could theoretically sometimes 
show “false positive” results, especially when describing 
subtle findings such as “accentuated bowel walls”. For di-
agnostic features such as “inflamed” or “affected” bowel 
wall there were statistically significant differences between 
HR-US and MRE. In this scenario, the US misses con-
sisted of  132 cases (53%), while MRE misses consisted 
of  just 6 cases (2%). Obviously MRE has some method-
ological advantages for decision making such as contrast 
media and better bowel distension because of  the oral 
contrast application before the examination.
Comparing our results with other studies we found 
the same tendencies in a study by Potthast et al[5] carried 
out in 2002. This group retrospectively compared 46 
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Table 4  Diagnostic performance of ultrasound and magnetic resonance enterography regarding bowel wall changes, diagnosis of bowel 
inflammation, stenosis, abscess, fistula and indirect inflammation signs such as local lymphadenopathy and fat injection or comb sign  n (%)
Bowel wall 
changes
Diagnosis “bowel 
wall inflammation”
Stenosis Abscess Fistula Local lymph-
adenopathy
Mesenteric fat 
injection/comb sign
US = MRE (no pathological change) 21 (8)   83 (33) 150 (60) 221 (84) 211 (88) 187 (75) 182 (73)
US = MRE (pathological change) 163 (65)   29 (12) 20 (8)   9 (4)   5 (2)   4 (2)   4 (2)
US > MRE   28 (11)   6 (2)   8 (3)   4 (2)   2 (1) 15 (6)   4 (2)
MRE > US   38 (15) 132 (53)   72 (29) 16 (6)   32 (13)   44 (18)   60 (24)
US: Ultrasound; MRE: Magnetic resonance enterography. In “US = MRE” the number (and percentage) of cases, when both modalities found the same 
amount of pathological features (patient based) are identical. For “US > MRE” the reports based on ultrasound described more pathological changes 
compared to the MRE, while for “MRE > US” more findings in the MRE reports were detected (because of truncation the percentage values in a column can 
exceed 100%).
HR-US MRE
Reduced imaging quality (obesity, breathing 
artifacts, residual bowel gas, etc.)
25   7
Region difficult to access (lesser pelvis) 72 N/A
Subtle findings 15 31
Table 5  Possible explanations for misdiagnosis of all evalu-
ated features (wall affection, stenosis, abscess, fistula, lymph 
nodes and indirect inflammation signs) for ultrasound and 
magnetic resonance enterography for all 250 evaluated cases
Magnetic resonance enterography (MRE) missed most of the diagnoses 
made by ultrasound (US) because of subtle US findings (n = 31), while the 
most common reason for a misdiagnosis based on the US report was an 
anatomical region difficult to assess (n = 72). N/A: Not available.
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patients undergoing MR enteroclysis with US and con-
ventional enteroclysis, surgery or colonoscopy as a gold 
standard. For bowel wall changes they calculated 22% 
false negative results for US and 2.4% false negative re-
sults for MRE. Martínez et al[6] in their prospective study 
of  30 patients with CD published different results. They 
compared US and MRI with regard to the extension and 
transmural complications in CD. For localization of  af-
fected bowel wall, US was not statistically significantly 
superior to MRI having a sensitivity of  91%, while MRI 
detected changes with a sensitivity of  83%. There are 
several major limitations of  this study. In addition to the 
small number of  patients, the authors accepted a time 
period of  up to 3 mo between the examinations and the 
standard of  reference. Also their choice of  the standard 
of  reference is very questionable. In addition to surgery 
they accepted conventional barium studies and small 
bowel follow-through examinations as a standard of  ref-
erence. In several studies these examinations showed a 
poorer sensitivity and accuracy than MRE[7].
A meta-analysis from 2008 on the diagnostic accuracy 
of  studies based on US, MRI, scintigraphy, CT and PET 
imaging in IBD, did not reveal any statistically significant 
differences between the modalities[3]. The authors calcu-
lated that on a patient basis, US had a sensitivity of  90% 
(range 78%-96%) and MRE had a sensitivity of  93% 
(range 82%-100%).
It is not possible to compare our results directly using 
sensitivity values, because we did not have any standard 
of  reference in our study and just compared the positive 
results from the two modalities performed in the same 
patient. Based on our data, MRE (11% missed cases) 
detected slightly more lesions than HR-US (15% missed 
cases). A certain problem in this study was the vagueness 
of  the diagnostic statements with regard to the affection 
and inflammation of  bowel wall segments. Because of  
the lack of  bowel distension and intravenous contrast ap-
plication in standard HR-US examinations it seems inher-
ent to the system that US examinations were frequently 
describes as an unspecific bowel wall thickening without 
calling a finding an inflammation or affection. In our 
study, US reports missed 53% of  the cases when evalu-
ating for terms such as “inflammation” or “affection”, 
while MRE just missed 2% in this scenario.
With regard to terms such as “lumen narrowing” and 
“stenosis” we found a highly significant difference be-
tween HR-US, which missed 29% of  the described steno-
ses, and MRE, which missed just 3%. There was certainly 
a problem with the exact definition of  stenosis for HR-
US and MRE. US has the advantage of  dynamic real-
time imaging, which allows an assessment of  peristalsis 
with consecutive appreciation of  a functional stenosis vs 
lumen narrowing. In MRE reports, a lumen narrowing 
of  more than 50% can be called a stenosis. MRE is not 
a real-time imaging modality using a standard MR pro-
tocol. The only way to identify a functional stenosis is to 
evaluate all MRI sequences along the time line, which are 
performed over 25 min. Theoretically, MRI could lead to 
an overstaging of  lumen narrowing calling it a “stenosis” 
because of  the lack of  functional real-time image data. 
In 17 of  the 72 cases with a stenosis diagnosed by MRE 
and not by US, the stenosis was not called functionally 
relevant in the MRE report, while US described a wall 
thickening in the same bowel segments. The localization 
of  misdiagnosed stenoses by US was responsible for 23 
of  the 72 discrepant cases. These stenoses were especially 
located in the lesser pelvis, which is difficult to assess 
by transabdominal US. Our results are in contrast to the 
prospective results of  48 patients published by Schmidt 
et al[8] in 2003. In this study, conventional enteroclysis was 
considered the standard of  reference with data acquisi-
tion between 1999 and 2000. They calculated a sensitiv-
ity of  56% for detecting stenosis when using US with a 
specificity of  97%, while MRI had a sensitivity of  44% 
with a specificity of  100%. On the other hand, the retro-
spectively performed comparison by Potthast et al[5] had 
a sensitivity of  58% for US with a false negative rate of  
16%, while MRI had a sensitivity of  100% with a false 
negative rate of  2%. In our study, 6 (75%) of  the 8 ex-
aminations with a superior US result were performed by 
a highly experienced examiner, while in the group of  su-
perior MRI results just 28 (39%) of  the 72 examinations 
were performed by the highly experienced group.
For abscess diagnosis the differences between HR-
US (16 missed abscesses) and MRE (4 missed abscesses) 
were statistically significant (P < 0.05). Considering the 
fact that all 4 abscesses diagnosed by US and not by MRE 
were most likely not present at the time of  MRE exami-
nation (n = 3) due to treatment or a false positive US 
result (n = 1; probably hemorrhagic ovarian cyst), MRE 
seems to be the superior modality for detecting abscesses 
in the abdomen.
For 13 (81%) of  the 16 cases with a missed abscess by 
HR-US, the localization of  the abscess in the lesser pelvis 
and peri-rectal region, which is difficult to assess by US, 
was the most plausible reason. Our results were mirrored 
in the study by Potthast et al[5], which showed a sensitivity 
of  100% for MRI and 89% for US. Another study from 
the same hospital attributed MRI with a sensitivity of  
83%, and US with a sensitivity of  67%[9].
For fistula detection, the differences between MRI, 
which missed 2 cases (1%), and HR-US, which missed 32 
cases (13%), were highly significant. The localization of  
the fistula in the lesser pelvis and peri-rectal region was 
a possible explanation in 24 of  the 32 cases. The experi-
ence of  the examiners did not have any influence on the 
results. It should be noted that HR-US examinations were 
restricted to transabdominal US examinations. A HR-
US examination performed transperineal or trans-rectally 
would most probably improve the results of  US dramati-
cally. When comparing dedicated US examinations such 
as endoscopic endorectal US to MRI, both modalities 
were found to have similar sensitivities and specifici-
ties[10-12]. The study by Potthast et al[5] supports our data, 
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showing a false negative rate of  26% for transabdominal 
US and 5% for MRI.
The mention of  a local lymphadenopathy is an indi-
rect unspecific sign of  an inflammatory process. Maconi 
et al[13] found an unspecific lymphadenopathy in 25% of  
their patients (n = 240) with CD using US. They detected 
more enlarged lymph nodes in young patients and in 
patients with fistulas and abscesses. In our study, MRE 
missed 15 cases (6%) with lymphadenopathy while US 
missed 44 cases (18%). There was an identical tendency 
in the evaluation of  local mesenteric fat injection and 
comb sign with a missed rate of  2% in MRI and 24% in 
HR-US.
One of  the major restrictions of  our study is the ret-
rospective approach used as well as the long data acqui-
sition period of  7 years using different equipment and 
different examination protocols. In addition there was no 
standard of  reference for the evaluated parameters. The 
retrospective evaluation of  consecutive patients was de-
liberately chosen to assess the actual quality of  MRE and 
US without influencing the examiners using both mo-
dalities. The quality improvements in HR-US over time 
were accompanied by improvements in MR imaging and 
protocols. However, basically identical protocols (fast T2 
weighted sequences as well as gradient echo sequences af-
ter contrast application) were used during the evaluation 
time period. Having a standard of  reference for all fea-
tures evaluated in this study was extremely difficult. For 
small bowel assessment, MRI together with multidetector 
CT is already considered an accepted standard of  refer-
ence with superior sensitivity and specificity compared 
to conventional enteroclysis and follow-through exami-
nations[2,3]. When considering surgery as the standard 
of  reference this would reduce the number of  patients 
included in the study dramatically. Therefore, we consid-
ered a pathological finding mentioned in one report as a 
real finding, which was also to be described in the other 
modality. The analysis of  32 of  250 examinations, which 
were performed in patients with UC makes the patients 
evaluated more inhomogeneous, but does not influence 
our results significantly. On the other hand, we intended 
to analyze a realistic scenario in patients suffering from 
IBD.
In the recent literature, there are no major studies evalu-
ating the diagnostic quality of  HR-US and MRI with regard 
to bowel wall affections as well as transmural complica-
tions such as abscesses or fistulas. In our study, MR imag-
ing was superior to US for all evaluated features. The dif-
ference was statistically significant for the diagnosis and 
detection of  an abscess and highly significant for stenosis 
and fistula evaluation.
In conclusion, transabdominal HR-US can miss a cer-
tain number of  pathological changes in patients with 
IBD. The localization of  the pathological lesions in ana-
tomical regions, which are difficult to assess by US, such 
as the lesser pelvis or the peri-rectal region, is one of  the 
most frequent reasons for a missing a diagnosis. When 
the clinical suspicion of  bowel affection or complications 
is mentioned, an MRI examination should be performed 
after an US examination without relevant findings.
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